Large, population-based, prospective cohorts will enable powerful studies of the determinants of Motor Neurone Disease, provided identification of disease cases is sufficiently accurate. We found that primary care datasets, particularly from countries with a widely-accessible national healthcare system, are potentially valuable data sources warranting further investigation.